| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10306955 | Psychosomatics | 2016 | 9 Pages |
Abstract
These data confirm the challenges of correctly diagnosing AD without using biomarkers. FBP-PET can aid AD dementia differential diagnosis by detecting amyloid pathology antemortem, even when the diagnosis of AD is made by expert clinicians.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Elisabeth K. R.N., M.S.N., Michael M. Ph.D., Michael G. M.S., Peng Ph.D., David B. M.D., Helen M. Pharm.D., Deborah N. Ph.D., M.B.A., Paula T. M.D.,